The latter opens the possibility of manipulating AQP4 levels as a therapeutic option to maintain vascular integrity under different neurodegenerative/neuroinflammatory conditions, in agreement with a recent study supporting the modulation of its subcellular localization for the treatment of brain edemas [46]. The gene discussed is AQP4; the disease is brain edema.